Cytokinetics Inc. buy Needham & Company LLC
Start price
20.10.23
/
50%
€31.40
Target price
20.10.24
€56.68
Performance (%)
92.68%
Price
06.05.24
€60.50
Summary
This prediction is currently active. With a performance of 92.68% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 20.10.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 5.217% | 5.217% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
09.04.24
09.04.24
€99.24
09.04.25
09.04.25
-11.03%
06.05.24
06.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€71.00
28.02.24
28.02.24
€99.73
28.02.25
28.02.25
-14.79%
06.05.24
06.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€73.50
27.12.23
27.12.23
€97.23
27.12.24
27.12.24
-17.69%
06.05.24
06.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
100.33%
06.05.24
06.05.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24